Gerresheimer AG (XTER:GXI) Research & Development : €13 Mil (TTM As of Feb. 2024)

View and export this data going back to 2007. Start your Free Trial

What is Gerresheimer AG Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Gerresheimer AG's Research & Development for the three months ended in Feb. 2024 was €6 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Feb. 2024 was €13 Mil.

Gerresheimer AG Research & Development Historical Data

The historical data trend for Gerresheimer AG's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gerresheimer AG Research & Development Chart

Gerresheimer AG Annual Data

Trend

Nov14

Nov15

Nov16

Nov17

Nov18

Nov19

Nov20

Nov21

Nov22

Nov23

Research & Development

Get a 7-Day Free Trial

3.59

7.66

9.97

21.62

16.13

Gerresheimer AG Quarterly Data
	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24
Research & Development	Get a 7-Day Free Trial															8.65	2.85	1.04	3.58	5.57

Gerresheimer AG Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €13 Mil.

Gerresheimer AG (XTER:GXI) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Gerresheimer AG Research & Development Related Terms

Thank you for viewing the detailed overview of Gerresheimer AG's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Gerresheimer AG (XTER:GXI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Gerresheimer AG (XTER:GXI) » Definitions » Research & Development

Comparable Companies

Traded in Other Exchanges

GXId:UK 0NTI:UK GXI:Germany GXI:Germany GXI:Germany GXI:Austria

Address

Klaus-Bungert-Strasse 4, Duesseldorf, NW, DEU, 40468

Website

https://www.gerresheimer.com

Gerresheimer AG provides medicine packaging, drug delivery devices, and solutions with a product range for pharma, health, well-being, and biotech. The firm operates in three segments: The plastics and devices segment consists of products for simple and safe drug delivery along with packaging for liquid and solid medicines, The primary packaging glass segment produces glass packaging products for the pharma and cosmetics industries also for food and beverage industry and The advanced technologies segment works on technical and digital solutions to improve the therapy outcome for patients. The company generates the majority of its revenue in Europe, with sales in Germany contributing the major proportion of any country.

Executives

Dietmar Siemssen	Board of Directors
Dr. Lukas Burkhardt	Board of Directors
Andrea Abt	Supervisory Board

Gerresheimer AG (XTER:GXI) Headlines

No Headlines